Dr. John Lavin, M.D.
What this data tells you about Dr. Lavin
Dr. John Lavin is an urology physician in San Antonio, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Lavin performed 3,577 Medicare services across 1,756 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lavin received a total of $1,371 from 14 pharmaceutical and/or device companies across 27 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lavin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test | 1,138 | $34 | $78 |
| Urinalysis with microscopic exam | 473 | $3 | $15 |
| Office visit, established patient (30-39 min) | 296 | $90 | $215 |
| Bladder ultrasound after voiding | 240 | $7 | $95 |
| Chronic care management, first 20 min/month | 205 | $40 | $80 |
| Office visit, established patient (20-29 min) | 202 | $61 | $150 |
| Blood draw (venipuncture) | 161 | $8 | $10 |
| Yeast/candida DNA test | 94 | $34 | $78 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 94 | $34 | $78 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 92 | $34 | $78 |
| PSA test (prostate cancer screening) | 74 | $18 | $110 |
| Basic metabolic blood panel | 60 | $8 | $45 |
| Diagnostic exam of bladder and urethra using an endoscope | 51 | $162 | $490 |
| New patient office visit (45-59 min) | 49 | $107 | $313 |
| Hospital follow-up visit, low complexity | 40 | $38 | $90 |
| Complete ultrasound scan behind abdominal cavity | 35 | $79 | $345 |
| Complete blood count (CBC) with differential | 34 | $8 | $25 |
| Biopsy of prostate gland | 26 | $76 | $350 |
| Ultrasound scan of pelvic region through rectum | 26 | $20 | $285 |
| New patient office visit (30-44 min) | 26 | $67 | $210 |
| Testosterone (hormone) level, total | 25 | $24 | $150 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 25 | $112 | $762 |
| Simple insertion of temporary bladder tube | 21 | $32 | $180 |
| Red blood cell concentration measurement | 20 | $2 | $8 |
| Blood count, hemoglobin | 20 | $2 | $8 |
| Initial hospital admission, moderate complexity | 18 | $100 | $275 |
| Simple bladder irrigation and/or instillation | 16 | $58 | $215 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 16 | $63 | $165 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lavin is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lavin experienced with infectious disease dna/rna test?
Does Dr. Lavin receive payments from pharmaceutical companies?
How do Dr. Lavin's costs compare to other urology physicians in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology